Drug Profile
Ivosidenib companion diagnostic - Abbott/Agios
Alternative Names: AG 120 companion diagnosticLatest Information Update: 24 Jul 2018
Price :
$50
*
At a glance
- Originator Abbott Laboratories; Agios Pharmaceuticals
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Acute myeloid leukaemia
Most Recent Events
- 20 Jul 2018 Registered for Acute myeloid leukaemia (Diagnosis) in USA (unspecified route) - First Global Approval (9245261; 9245259)
- 15 Feb 2018 Preregistration for Acute myeloid leukaemia (Diagnosis) in USA (unspecified route)
- 12 Oct 2016 Clinical trials in Acute myeloid leukaemia (Diagnosis) in USA (unspecified route)